Format

Send to

Choose Destination
Clin Cancer Res. 2019 Jan 1;25(1):35-42. doi: 10.1158/1078-0432.CCR-17-3375. Epub 2018 Jun 6.

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.

Author information

1
Radio-Oncology Laboratory, Department of Radiation Oncology, Lausanne University Hospital, Lausanne, Switzerland. marie-catherine.vozenin@chuv.ch.
2
Micen-vet, Créteil, France.
3
Radio-Oncology Laboratory, Department of Radiation Oncology, Lausanne University Hospital, Lausanne, Switzerland.
4
Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.
5
Institut Curie, INSERM U1021/CNRS UMR3347, Université Paris-Sud, Orsay, France.
6
Service de Chirurgie Expérimentale, Département de chirurgie et anesthésie, Lausanne University Hospital, Lausanne, Switzerland.
7
UNIL, Lausanne, Switzerland.
#
Contributed equally

Abstract

PURPOSE:

Previous studies using FLASH radiotherapy (RT) in mice showed a marked increase of the differential effect between normal tissue and tumors. To stimulate clinical transfer, we evaluated whether this effect could also occur in higher mammals.

EXPERIMENTAL DESIGN:

Pig skin was used to investigate a potential difference in toxicity between irradiation delivered at an ultrahigh dose rate called "FLASH-RT" and irradiation delivered at a conventional dose rate called "Conv-RT." A clinical, phase I, single-dose escalation trial (25-41 Gy) was performed in 6 cat patients with locally advanced T2/T3N0M0 squamous cell carcinoma of the nasal planum to determine the maximal tolerated dose and progression-free survival (PFS) of single-dose FLASH-RT.

RESULTS:

Using, respectively, depilation and fibronecrosis as acute and late endpoints, a protective effect of FLASH-RT was observed (≥20% dose-equivalent difference vs. Conv-RT). Three cats experienced no acute toxicity, whereas 3 exhibited moderate/mild transient mucositis, and all cats had depilation. With a median follow-up of 13.5 months, the PFS at 16 months was 84%.

CONCLUSIONS:

Our results confirmed the potential advantage of FLASH-RT and provide a strong rationale for further evaluating FLASH-RT in human patients.See related commentary by Harrington, p. 3.

PMID:
29875213
DOI:
10.1158/1078-0432.CCR-17-3375
Free full text

Supplemental Content

Full text links

Icon for HighWire Icon for HAL archives ouvertes
Loading ...
Support Center